Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Nanochip Technology for Monitoring Treatment Response and Detection of Relapse in Patients With Diffuse Large B-Cell Lymphoma

NCT03656835 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT03656835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Nanochip Technology for Monitoring Treatment Response and Detection of Relapse in Patients With Diffuse Large B-Cell Lymphoma
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 26, 2018
Completion date
May 30, 2027
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma, diffuse large b-cell lymphoma germinal center b-cell type, diffuse large b-cell lymphoma, not otherwise specified, high grade b-cell lymphoma